Eyes On 2027 sets sail next week!
Final boarding call! Eyes On 2027 embarks November 6-7, and there’s still a spot on deck for you. Sign up now for 12 virtual clinical sessions covering the most critical eyecare advances across every specialty. Plus, earn up to 8 COPE-accredited CE hours, ask experts questions live, and enter to win up to $2,000 in raffle prizes!
New Content
The Next Era of Ophthalmology: Why Glaucoma and Cataract Treatment is Reaching an “iPhone Moment"
Rapid-Fire Retina: TKIs, Gene Therapy, and the Durability Race
Join Drs. John Kitchens and David Eichenbaum as they discuss updates in the retina pipeline and what therapies ophthalmologists should keep on their radar.
How I Made CareCredit Simple for My Team and Patients
Dr. Brianna Rhue shares practical ways eyecare practice teams can simplify CareCredit for staff and patients through training, workflows, patient conversations, and performance tracking.
Stabilizing the Tear Film Prior to Cataract Surgery
Sit down with Drs. Preeya K. Gupta and Vance Thompson to review approaches for efficiently addressing tear film instability before cataract surgery.
Topics
The First Line of Dry Eye Care—No Prescription Required
Beyond Co-Management: A New Growth Model for Optometry Practices
How optometrists are expanding their patient care capabilities through office-based surgery
Report: Rural residents face steep gap in retina care access
One in three rural Americans lives beyond an hour's drive of a retina specialist.
FDA grants Orphan Drug designation to Octant's RP oral therapy
Oral small molecule is designed to correct protein misfolding for RHO gene mutations, the root cause of RHO-adRP; phase 1/2 clinical study currently underway.
Leadership watch: LENZ, CooperCompanies CEOs step down, among exec changes
Leadership changes are underway in the eyecare space—and we’ve got the latest.
The Next Era of Ophthalmology: Why Glaucoma and Cataract Treatment is Reaching an “iPhone Moment"
As the biopharma industry pursues increasingly complex breakthroughs, some of the most transformative innovations may come not from inventing new categories of medicine, but from reimagining how proven technologies and therapies can work together in scalable, integrated delivery systems. In ophthalmology, that shift has the potential to fundamentally change the management of chronic disease. And it’s happening now, right before our eyes.
2026 Contact Lens Report
Download the free report to learn how optometrists are managing their contact lens practices in 2026!
Rapid-Fire Retina: TKIs, Gene Therapy, and the Durability Race
Join Drs. John Kitchens and David Eichenbaum as they discuss updates in the retina pipeline and what therapies ophthalmologists should keep on their radar.
Clinical Specialties
Stabilizing the Tear Film Prior to Cataract Surgery
The First Line of Dry Eye Care—No Prescription Required
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.
How I Made CareCredit Simple for My Team and Patients
Dr. Brianna Rhue shares practical ways eyecare practice teams can simplify CareCredit for staff and patients through training, workflows, patient conversations, and performance tracking.
The Impact of Presbyopia Drops on Optical Sales
Join Drs. Schaeffer and Chima as they discuss the impact of prescribing presbyopia drops on optical sales and patient care in clinical practice.
Careers
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Beyond the Sales Rep: Understanding Who’s Who in Industry
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
The Next Era of Ophthalmology: Why Glaucoma and Cataract Treatment is Reaching an “iPhone Moment"
As the biopharma industry pursues increasingly complex breakthroughs, some of the most transformative innovations may come not from inventing new categories of medicine, but from reimagining how proven technologies and therapies can work together in scalable, integrated delivery systems. In ophthalmology, that shift has the potential to fundamentally change the management of chronic disease. And it’s happening now, right before our eyes.
